Embolotherapy Market by Disease (Aneurysm, Oncology, Peripheral Vascular), Product (Guidewires, Embolic Agents (Detachable Coils, Microspheres, Pushable Coils)), Procedure, End User (Clinics, Hospitals, Academia, ASC) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Global embolotherapy market is expected to surpass USD 5.3 billion by 2025 from USD 3.5 billion in 2019 with a CAGR of 8.5%

04-Sep-2019 | Number of pages: 130 | Report Code: ZMR-4673 | Report Format : | Status : Published

Abstract

Global Embolotherapy Market: An Overview

The global embolotherapy market is a fragmented, and competitive landscape. The rising demand for embolotherapy to treat cases of trauma, tumor, and for male infertility, and impotence promises major growth for the market in near future.

Embolotherapy today plays a more important role in medicine than ever before. The treatment, endovascular in nature promises to control bleeding, reduction in tumors, close arteriovenous, among others. The technique is increasingly moving towards minimal-invasive procedures which will likely present major benefits to the rising elderly, and chronic-disease ridden patient population. The success of the treatment relies on a wide variety of gel foams, angiographic catheters, coils, balloons, and skilled surgeons. The therapy can be permanent or temporary in nature, and varies widely depending on the application.

According to ZMR’s latest study, the embolotherapy market will register significant growth during 2019-2025, growing at a robust 8.5% CAGR. The rising investments, grants by public and private institutions, and rising cases of chronic illnesses like liver cancer will spell major growth for the market during the forecast period. According to the ZMR study, the market reached a valuation of $3.5 bn in 2019, and will likely cross $5.3 bn by 2025 end.

Global Embolotherapy Market: Key Trends

According to the latest reports by Center for Disease Control and Prevention (CDC), each year 33,000 people in the US are diagnosed with liver cancer. Among these, over 27,000 patients die from the illness. Additionally, the percentage of people receiving liver cancer has steadily been on the rise in the last decade. Moreover, the percentage of people who survive beyond five years remains extremely low with percentage hovering between 4 to 26.

On the other hand, strokes also remains a key opportunity for improving the lives of patients for players in the global embolotherapy market. Strokes remains the fifth-leading cause of deaths in the United States, with 7,95,000 cases incidences reported annually.

Additionally, diseases like uterine fibroid are also witnessing a growing rate of diagnosis, thanks to rising awareness of the disease, and increasingly effective treatment procedure. The disease remains a common occurrences among women. Most women develop the condition between 20-80 years of age, and 35% of women experience the condition before they reach menopause.

The rising occurrences of several chronic diseases including cancer, strokes, and their growing adverse effects on the elderly population will create significant opportunities for growth in the global embolotherapy market in near future.

Global Embolotherapy Market: Segmentation

The global embolotherapy market report is segmented on the basis of disease, products, procedure, end-users, and region. Among type of disease, oncology, aneurysm, peripheral vascular conditions will be studied. The product segement of the report will cover guidewires, detachable coils, embolic agents, pushable coils, and microspheres. Moreover, the data from clinics, hospitals, academia, and ASC will also be presented in the end-user segment.

Global Embolotherapy Market: Regional Analysis

The global embolotherapy market will cover all key regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, the rising investment in healthcare in the US, will likely create major opportunities for growth in the North America region. Recent legislations in the US has extended programs like Medicare for all elderly patients above 65 years of age. Among other regions, the Asia Pacific region will likely witness highest CAGR-driven growth, thanks to rising disposable income, and growing access to healthcare.

Global Embolotherapy Market: Competitive Analysis

The global embolotherapy market remains an innovative landscape, wherein large fragmentation in the market continues to drive robust innovation. The growing technological advancements, and increasing demand for minimal-invasive surgeries will also fuel further growth for innovation during the forecast period. Some key players in the global embolotherapy market are Merit Medical Systems, Boston Scientific Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd.

 The global embolotherapy market is segmented as follows:

By Product

  • Embolic agents
  • Microspheres
  • Embolic coils
    • Detachable Coils
    • Pushable Coils
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Detachable Balloons
  • Support Devices
  • Microcatheters
  • Guidewires

By Disease Indication

  • Cancer
  • Liver Cancer
  • Kidney Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Neurological Diseases
  • Cerebral Aneurysm
  • Cerebral Arteriovenous Malformations and Fistulas
  • Gastrointestinal Disorders
  • Urological and Nephrological Disorders

By Procedure

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions

The global embolotherapy market was valued at USD$3.5 bn in 2019.

The global embolotherapy market will likely reach $5.3 bn by 2025.

The global embolotherapy market will rise at a promising 8.5% CAGR during 2019-2025 period.

North America will likely register highest total revenues during the forecast period, while Asia Pacific region will grow at the fastest CAGR.

Some main players in the global embolotherapy market include Merit Medical Systems, Boston Scientific Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd.

Related Reports

Artificial Disc Market – By Type (Lumbar Artificial Disc and Cervical Artificial Disc), By Material (Metal-On-Biopolymer and Metal-On-Metal), And By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2025

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5311 | Report Format:

This report analyzes and estimates the artificial disc market at global, regional, and country level. The research study provides historic data from 2015 to 2019 along with the forecast from 2020 to 2025 based on revenue (USD Billion). The report offers detailed insights of the artificial disc mar...Read More

Medical Equipment Financing Market – By Type (Refurbished Equipment, New Medical Equipment, and Rental Equipment), By Equipment (Patient Monitoring Equipment, Diagnostic Equipment, Laboratory Equipment, Therapeutic Equipment, and Medical Furniture), By End-Use [Hospitals, Laboratories & Diagnostic Centers, Clinics, Ambulatory Surgical Centers (ASCs), and Others], and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2025

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5285 | Report Format:

This report analyzes and estimates the medical equipment financing market at global, regional, and country level. The research study provides historic data from 2015 to 2019 along with the forecast from 2020 to 2025 based on revenue (USD Billion). The report offers detailed insights of the medical...Read More

Endoscopy Fluid Management Market by Product (Hysteroscopy Pumps, Hysteroscopy Fluid Management Systems, Laparoscopy Suction Irrigation Pumps and Laparoscopy Fluid Management Systems); by Modality (Benchtop and Floor Standing); by End User (Specialty Clinics, Diagnostic Centers, Hospitals and Ambulatory Surgical Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Feb-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5252 | Report Format:

The report covers forecast and analysis for the endoscopy fluid management market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the endoscopy fluid manag...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.